미국의 집단건강관리 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 제공 방식별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

U.S. Population Health Management Market Summary

The U.S. population health management market size was estimated at USD 36.04 billion in 2024 and is projected to reach USD 210.18 billion by 2033, growing at a CAGR of 21.70% from 2025 to 2033. The market growth is majorly driven by the rising demand for healthcare IT services and solutions that support value-based healthcare delivery, resulting in a transition from Fee-For-Service (FFS) to a Value-Based Payment (VBP) model.

Increasing healthcare expenditure, the rising need for value-based healthcare, and effective disease management across different care settings are expected to drive the growth of the U.S. population health management industry. More than 130 million people in the U.S. suffer from at least one chronic condition. For instance, according to the data published by the Centers for Disease Control and Prevention (CDC) in February 2024, an estimated 129 million people in the U.S. live with at least one major chronic disease.

Population health management solutions based on open Application Programming Interfaces (APIs) are helpful for the management of chronic conditions with high treatment costs, such as cardiac diseases, asthma, and diabetes. PHM solutions also help reduce the cost of care, improve patient outcomes. PHM software also enables better analysis of patient data to make informed decisions.

Moreover, the implementation of population health management (PHM) facilitates the identification of at-risk patients and enhances disease prevention and management, resulting in financial savings. The Centers for Medicare & Medicaid Services (CMS) has introduced the Value-Based Payment Modifier to promote the adoption of PHM systems. This modifier offers varying payment rates to physician groups based on the quality of care provided, rather than the cost of care incurred during their performance period.

In the U.S., providers, payers, and accountable care organizations promote PHM systems. Many providers and payers require upgrading and automating their healthcare management systems, which is anticipated to improve healthcare delivery and help departments collaborate. The providers mainly focus on chronic diseases, such as diabetes and cardiovascular disorders, which are generally responsible for significant healthcare costs. The rising prevalence of lifestyle disorders has increased the need for effective management of the disease burden on healthcare centers.

Furthermore, key players are engaged in strategic initiatives, such as the launch of new products, partnerships and collaborations, mergers and acquisition activities, etc., which contribute to market growth. For instance, in May 2025, Oracle, the Cleveland Clinic, and G42 announced a strategic partnership to develop an AI-based global healthcare platform. This platform will leverage AI, large-scale data analytics, and clinical expertise to deliver scalable, affordable care models, enhancing patient outcomes, precision medicine, and public health management across the U.S. and UAE.

U.S. Population Health Management Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the U.S. population health management market report based on product, delivery mode, and end use:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Software
• Services
• Delivery Mode Outlook (Revenue, USD Million, 2021 - 2033)
• On-Premise
• Cloud-based
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Providers
• Payers
• Employer Groups

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Delivery Mode Segment
  • 1.2.3. End Use
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Population Health Management Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenges analysis
• 3.3. Population Health Management Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
    • 3.3.2.4. Environmental Landscape
    • 3.3.2.5. Legal Landscape
    • 3.3.2.6. Social Landscape

Chapter 4. U.S. Population Health Management Market: Product Estimates & Trend Analysis

• 4.1. Segment Definition
• 4.2. Product Movement Analysis & Market Share, 2024 & 2033
• 4.3. U.S. Population Health Management Market: Product Segment Dashboard
• 4.4. U.S. Population Health Management Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
  • 4.4.1. Software
    • 4.4.1.1. Software market estimates and forecast, 2021 - 2033 (USD Million)
  • 4.4.2. Services
    • 4.4.2.1. Services market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 5. U.S. Population Health Management Market: Delivery Mode Estimates & Trend Analysis

• 5.1. Segment Definition
• 5.2. Delivery Mode Movement Analysis & Market Share, 2024 & 2033
• 5.3. U.S. Population Health Management Market: Delivery Mode Segment Dashboard
• 5.4. U.S. Population Health Management Market Estimates & Forecasts, by Delivery Mode, 2021 to 2033 (USD Million)
  • 5.4.1. On-Premise
    • 5.4.1.1. On-Premise estimates and forecast, 2021 - 2033 (USD Million)
  • 5.4.2. Cloud-based
    • 5.4.2.1. Cloud-based estimates and forecast, 2021 - 2033 (USD Million)

Chapter 6. U.S. Population Health Management Market: End Use Estimates & Trend Analysis

• 6.1. Segment Definition
• 6.2. End Use Movement Analysis & Market Share, 2024 & 2033
• 6.3. U.S. Population Health Management Market: End Use Segment Dashboard
• 6.4. U.S. Population Health Management Market Estimates & Forecasts by End Use, 2021 to 2033 (USD Million)
  • 6.4.1. Healthcare Providers
    • 6.4.1.1. Healthcare Providers market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.4.2. Payers
    • 6.4.2.1. Payers market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.4.3. Employer Groups
    • 6.4.3.1. Employer groups market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 7. U.S. Population Health Management Market - Competitive Analysis

• 7.1. Participant Overview
• 7.2. Financial Performance
• 7.3. Product Benchmarking
• 7.4. Company Categorization
• 7.5. Company Market Position Analysis
• 7.6. Company Profiles
  • 7.6.1. Veradigm LLC
    • 7.6.1.1. Company overview
    • 7.6.1.2. Financial performance
    • 7.6.1.3. Product benchmarking
    • 7.6.1.4. Strategic Initiatives
  • 7.6.2. Oracle
    • 7.6.2.1. Company overview
    • 7.6.2.2. Financial performance
    • 7.6.2.3. Product benchmarking
    • 7.6.2.4. Strategic Initiatives
  • 7.6.3. Conifer Health Solutions, LLC
    • 7.6.3.1. Company overview
    • 7.6.3.2. Financial performance
    • 7.6.3.3. Product benchmarking
    • 7.6.3.4. Strategic Initiatives
  • 7.6.4. eClinicalWorks
    • 7.6.4.1. Company overview
    • 7.6.4.2. Financial performance
    • 7.6.4.3. Product benchmarking
    • 7.6.4.4. Strategic Initiatives
  • 7.6.5. Enli Health Intelligence
    • 7.6.5.1. Company overview
    • 7.6.5.2. Financial performance
    • 7.6.5.3. Product benchmarking
    • 7.6.5.4. Strategic Initiatives
  • 7.6.6. McKesson Corporation
    • 7.6.6.1. Company overview
    • 7.6.6.2. Financial performance
    • 7.6.6.3. Product benchmarking
    • 7.6.6.4. Strategic Initiatives
  • 7.6.7. Medecision
    • 7.6.7.1. Company overview
    • 7.6.7.2. Financial performance
    • 7.6.7.3. Product benchmarking
    • 7.6.7.4. Strategic Initiatives
  • 7.6.8. Optum, Inc.
    • 7.6.8.1. Company overview
    • 7.6.8.2. Financial performance
    • 7.6.8.3. Product benchmarking
    • 7.6.8.4. Strategic Initiatives
  • 7.6.9. Advisory Board
    • 7.6.9.1. Company overview
    • 7.6.9.2. Financial performance
    • 7.6.9.3. Product benchmarking
    • 7.6.9.4. Strategic Initiatives
  • 7.6.10. Koninklijke Philips N.V.
    • 7.6.10.1. Company overview
    • 7.6.10.2. Financial performance
    • 7.6.10.3. Product benchmarking
    • 7.6.10.4. Strategic initiatives
  • 7.6.11. athenahealth, Inc.
    • 7.6.11.1. Company overview
    • 7.6.11.2. Financial performance
    • 7.6.11.3. Product benchmarking
    • 7.6.11.4. Strategic initiatives
  • 7.6.12. RedBrick Health
    • 7.6.12.1. Company overview
    • 7.6.12.2. Financial performance
    • 7.6.12.3. Product benchmarking
    • 7.6.12.4. Strategic initiatives
  • 7.6.13. Welltok
    • 7.6.13.1. Company overview
    • 7.6.13.2. Financial performance
    • 7.6.13.3. Product benchmarking
    • 7.6.13.4. Strategic initiatives